The significance of ‘pipefill’ in two generic drug damages awards
Wednesday, October 18, 2017 @ 9:03 AM | By Greg McEvoy
In early 2017 the Federal Court issued decisions involving two significant damages awards under s. 8 of the Patented Medicines (Notice of Compliance) Regulations. An important component of these damages awards...